Thyroid Screening in the Sports Nutrition Intake: TSH-Free T4-Free T3 Interpretation, the Subclinical-Hypothyroidism Red Flag, and the Endocrine-Referral Trigger
A masters distance runner with declining splits and a TSH of 4.8 mIU/L ends up with a hypothyroid label, a levothyroxine prescription, and performance that does not return because the workup never asked the right second question. Thyroid lab values in athletes carry a different interpretive load than in the sedentary population: low-T3 syndrome from energy deficit, training-induced TSH suppression, and the female-athlete differential against RED-S all sit in the same numbers a primary-care workup reads at face value. Here is the structured thyroid workup the sports RD should run when a TSH or Free T4 lands on the intake: a five-dimension interpretive frame, the four-quadrant clinical matrix, the energy-availability and iron co-dependencies, and the SOAP pattern that gets the case co-managed correctly with endocrinology.
A 42-year-old masters distance runner walks into intake with a four-month run of declining splits, persistent fatigue, cold intolerance she has never had before, and a 6-pound unintentional weight gain that the scale will not give back. Her primary-care physician ran a thyroid panel three weeks ago. TSH is 4.8 mIU/L. Free T4 is 1.0 ng/dL. Free T3 was not ordered. Reverse T3 was not ordered. Thyroid peroxidase antibodies were not ordered. The PCP has prescribed 25 mcg of levothyroxine daily, told her to recheck TSH in 8 weeks, and sent her on her way. She has been on the medication for two weeks. Her splits have not recovered. Her energy has not recovered. She is in the office because her coach told her to find someone who understands athletes.
The thyroid workup that produced her diagnosis is the wrong instrument for her presentation. A TSH of 4.8 with a Free T4 of 1.0 in a sedentary 42-year-old is subclinical hypothyroidism and, in the absence of symptoms, is typically watched rather than treated; the same numbers in a masters endurance athlete with declining performance, weight gain, and cold intolerance is a case that warrants the full workup the PCP did not run. The interpretive load is different. The differential is different. The intervention sequence is different. And the most common upstream driver — chronic energy deficit producing low-T3 syndrome and a compensatory TSH rise — is not on the PCP's checklist at all.
Most sports-RD intakes do not run a structured thyroid workup. The thyroid panel arrives from primary care, the TSH is the headline, the athlete is told she has "a thyroid problem," and the case proceeds as a thyroid-replacement-therapy case rather than as the multi-variable workup the presentation actually requires. The athlete who walks in with a TSH of 4.8 and declining performance is rarely a simple hypothyroid case. She is much more often an under-fueled athlete with secondary thyroid suppression, an iron-deficient athlete whose ferritin is dragging her TSH up through the iron-TPO co-factor pathway, an autoimmune-thyroid athlete whose Hashimoto presentation has been missed because TPO antibodies were never ordered, or some combination of all three. The RD who reads the panel through the right interpretive frame catches the dominant driver. The RD who reads only the TSH echoes the PCP's surface read and ships the same incomplete workup forward.
This post is the thyroid screening protocol I run when a thyroid panel shows up in the sports-nutrition intake. The five-dimension interpretive frame, the four-quadrant clinical decision matrix, the energy-availability and iron differential that drives most of the cases, the endocrine-referral triggers, the common counseling mistakes, and the SOAP documentation that captures the case defensibly.
Why the standard thyroid workup misses athlete physiology
Three structural reasons.
The TSH reference range was calibrated on a sedentary, non-pregnant, non-athletic adult population. Most US labs report the reference range as 0.4 to 4.5 mIU/L, with values above 4.5 flagged as elevated and values between 2.5 and 4.5 in a gray zone that primary-care guidelines treat conservatively (watch, do not necessarily treat). The athletic-population data tells a more nuanced story: endurance athletes in heavy training often run TSH values toward the lower half of the reference range (0.5-2.5) with normal Free T4 and Free T3, reflecting training-state adaptation rather than hyperthyroidism; athletes in chronic energy deficit often run TSH values toward the upper half of the reference range (3.0-5.0) with low-normal Free T3, reflecting compensatory pituitary upregulation in response to the suppressed peripheral conversion of T4 to T3 that the energy deficit drives. The same TSH number describes two different metabolic states depending on the upstream physiology.
The panel rarely includes the values that actually discriminate the differential. A standard PCP thyroid panel orders TSH alone, or TSH plus Free T4. Free T3 is often dropped because the PCP guideline considers it unnecessary for routine screening. Reverse T3 is almost never ordered outside endocrinology referral. Thyroid peroxidase (TPO) antibodies are not ordered unless the TSH is overtly elevated. The result is a panel that flags the gross hypothyroid case but misses the low-T3 syndrome, the Hashimoto-positive subclinical case, and the thyroid-resistance differential that requires reverse T3 to disambiguate. The sports-RD workup has to read across the values the PCP panel includes and infer the values the panel left out — or, more often, order the missing pieces through the athlete's primary-care or endocrine pathway.
The intervention path the PCP defaults to does not address the upstream driver in athletes. Levothyroxine replaces T4 and lets the body convert to T3 peripherally. In an athlete whose suppressed Free T3 is being driven by chronic energy deficit, levothyroxine raises the T4 pool but does not restore the deiodinase-mediated conversion to T3 that the energy deficit has down-regulated. The PCP recheck at 8 weeks shows a modest TSH drop and the athlete is told the medication is working, but the symptoms persist because the dominant driver — the energy deficit — has not been addressed. The intervention has produced a chart-trail of improvement without a functional change in the athlete's physiology.
The five-dimension thyroid workup
Dimension 1: TSH interpretation against the athletic-population frame. Read the TSH against the athlete's training state, not against the sedentary reference range. A TSH of 1.2 in a heavy-training endurance athlete with normal Free T4 and Free T3 is normal training-adapted physiology, not hyperthyroidism. A TSH of 3.8 in an endurance athlete with documented chronic energy deficit and low-normal Free T3 is compensatory-rise physiology, not subclinical hypothyroidism in the conventional sense — the intervention is the energy-availability fix, not levothyroxine. A TSH consistently above 5.0 across two draws, with symptoms, with elevated TPO antibodies, or with a Free T4 below the reference range, is a real thyroid case that warrants endocrine evaluation regardless of training state.
Dimension 2: Free T3 as the functional marker. The active hormone at the cellular receptor is T3, not T4. An athlete with normal Free T4 and low-normal Free T3 (below the lower third of the reference range) is showing the low-T3 pattern that low energy availability, chronic carbohydrate restriction, and overtraining all produce. The panel that omits Free T3 misses this signal entirely. Where the PCP panel did not include Free T3, the sports-RD case-management work is to request the addition on the next draw, paired with the [LEA-Q screening protocol](/blog/screening-athletes-for-low-energy-availability) and the [iron-status workup](/blog/iron-status-workup-in-female-athletes) that the same case usually warrants.
Dimension 3: TPO antibodies as the autoimmune flag. Hashimoto thyroiditis is the most common cause of clinical hypothyroidism in adults and runs 5-10x more common in female athletes than in male athletes. A TPO antibody titer above 35 IU/mL (or the upper reference range for the lab) in an athlete with TSH 2.5-5.0 and gradually declining performance is the autoimmune-thyroid case that warrants endocrine co-management regardless of how the TSH alone reads. The standard PCP panel omits TPO unless the TSH is overtly elevated, which means the early Hashimoto case — where intervention has the highest leverage — is the case the standard screen misses most often.
Dimension 4: Reverse T3 and the T3/rT3 ratio as the conversion marker. Reverse T3 is the metabolically inactive isomer of T3, produced by the same deiodinase enzymes that produce active T3. Under stress, energy deficit, and acute illness, deiodinase activity shifts toward reverse T3 production at the expense of active T3, suppressing the functional thyroid signal at the cellular receptor even when TSH and Free T4 look normal. A T3-to-reverse-T3 ratio below 10:1 (some clinicians use 20:1 as the threshold; the literature is not yet standardized) is consistent with the low-T3, high-rT3 pattern that chronic stress, overtraining, and under-fueling produce. Reverse T3 is rarely ordered outside endocrinology; the sports-RD case-management work is to request it when the differential warrants and the athlete's primary care will support it.
Dimension 5: Iron status as the co-dependency. Thyroid peroxidase is an iron-dependent enzyme; ferritin below 30 ng/mL impairs the enzyme's function and can produce a relative hypothyroid state independent of the thyroid gland itself. Female athletes with thyroid presentations and ferritin below 30 — a population overlap that is the rule, not the exception — frequently have the iron deficiency as the dominant driver of the thyroid signal. The intervention sequence is the iron repletion first, with re-evaluation of the thyroid panel after the ferritin is above 50 for 8-12 weeks. The [iron-status workup protocol](/blog/iron-status-workup-in-female-athletes) is the parallel workup that should run on every female athlete with a thyroid presentation.
The four-quadrant clinical decision matrix
The five dimensions collapse into a four-quadrant matrix that drives the intervention sequence.
Quadrant 1: Normal panel, normal symptoms, training-state-adapted. TSH inside the athletic-physiology range, Free T4 and Free T3 in the upper half of reference, TPO antibodies negative, no symptoms inconsistent with training load. No intervention indicated. The thyroid panel was a screen and it screened negative. Document the normal read and proceed with the consult complaint.
Quadrant 2: Borderline TSH, low Free T3, energy-deficit pattern present. TSH 2.5-5.0, Free T4 mid-range, Free T3 in the lower third of reference, TPO antibodies negative, LEA screen positive or energy-deficit history present. The intervention is the [low energy availability fix](/blog/screening-athletes-for-low-energy-availability), with re-evaluation of the thyroid panel after 8-12 weeks of restored energy availability. The thyroid pattern in this quadrant is downstream of the energy deficit and resolves with the upstream intervention in the large majority of cases. Do not start levothyroxine; do work the energy intervention.
Quadrant 3: Borderline TSH, normal Free T3, TPO positive. TSH 2.5-5.0, Free T4 mid-range, Free T3 mid-range, TPO antibodies above the reference upper limit. The autoimmune-thyroid case, often in the pre-clinical phase before frank hypothyroidism develops. Co-management with endocrinology is indicated. The dietetic intervention is iodine adequacy (avoid both deficiency and excess), selenium adequacy (100-200 mcg/day supports thyroid-antibody reduction in some Hashimoto cases), and the inflammation-reduction nutrition pattern (omega-3 adequacy, adequate vitamin D, glycemic management). Re-evaluate at the endocrine-co-management cadence.
Quadrant 4: TSH above 5.0 or below 0.4, symptomatic. Frank thyroid dysfunction (either overt hypothyroidism or hyperthyroidism). Refer to endocrinology immediately. The dietetic intervention is supportive of the medical workup, not the primary driver.
When to refer to medical
Five signals warrant medical referral beyond the dietetic workup.
TSH above 10 mIU/L on any draw. Overt hypothyroid range. Endocrine evaluation regardless of clinical picture.
TSH below 0.1 mIU/L on any draw. Overt hyperthyroid range or exogenous-hormone suppression. Endocrine evaluation regardless of clinical picture.
TPO antibodies above 100 IU/mL in an athlete with declining performance. Aggressive autoimmune-thyroid case that warrants endocrine co-management.
Family history of thyroid cancer, palpable thyroid nodule, or thyroid asymmetry on exam. Imaging workup and endocrine referral are the appropriate pathway regardless of lab values.
Pregnancy or planning pregnancy in a female athlete with any abnormal thyroid value. Pregnancy thyroid management is its own clinical surface; refer to OB and endocrinology jointly.
Common counseling mistakes
Reading the TSH at face value without the athletic-physiology frame. A TSH of 1.2 in a heavy-training endurance athlete is not hyperthyroidism. A TSH of 3.8 in an under-fueled female athlete is not subclinical hypothyroidism in the conventional sense; it is downstream of the energy deficit and resolves with the upstream intervention.
Accepting the PCP panel as adequate without requesting Free T3 and TPO antibodies. The standard PCP panel misses the values that drive the athletic-population differential. The sports-RD case-management work is to request the additions through the athlete's care team.
Counseling levothyroxine adherence without addressing the upstream driver. In athletes whose thyroid pattern is downstream of energy deficit or iron deficiency, the levothyroxine prescription does not produce the symptomatic recovery the athlete is looking for, and the chart trail shows a modest TSH improvement without a functional change. The dietetic intervention has to address the upstream driver in parallel.
Counseling iodine supplementation reflexively for any thyroid case. Iodine adequacy is required for thyroid function, but excess iodine is a well-documented trigger for Hashimoto flare and can worsen the autoimmune-thyroid case. The intervention is dietary adequacy (150 mcg/day RDA, modest seafood and iodized salt intake), not high-dose iodine supplementation outside a defined medical indication.
Skipping the iron-status workup in female athletes with thyroid presentations. The iron-thyroid co-dependency is well-described and produces a thyroid signal that resolves with iron repletion. The [iron-status workup protocol](/blog/iron-status-workup-in-female-athletes) should run on every female athlete with an abnormal thyroid value.
Counseling soy-elimination, gluten-elimination, or other restrictive interventions on the basis of social-media protocols. The evidence base for these interventions in non-celiac, non-autoimmune-flagged populations is weak, and the restrictive intervention can compromise energy availability in athletes whose dietary pattern was already marginal. The sports-RD intervention is energy-availability adequacy, micronutrient adequacy (iodine, selenium, iron, vitamin D), and inflammation-reduction patterns — not blanket food eliminations.
Failing to coordinate with the athlete's primary care or endocrinology. Thyroid management is medical management. The sports-RD intervention runs in parallel with the medical workup, not in place of it. The chart trail has to show the coordination — what was communicated, what was requested, what was deferred to medical.
Where this lands in the SOAP
Subjective section format:
```
Thyroid Workup (panel reviewed YYYY-MM-DD):
- TSH: [X mIU/L, lab reference range]
- Free T4: [X ng/dL, lab reference range]
- Free T3: [X pg/mL, lab reference range, or NOT ORDERED]
- Reverse T3: [X ng/dL, or NOT ORDERED]
- TPO antibodies: [X IU/mL, or NOT ORDERED]
- Thyroglobulin antibodies: [X IU/mL, or NOT ORDERED]
Athletic-physiology context:
- Training state: [in-season / off-season / heavy training / detraining]
- Energy availability screen: [LEA-Q score, positive/negative]
- Iron status: [ferritin X ng/mL, sat X%, hemoglobin X g/dL]
- Symptoms: [list]
- Performance trajectory: [trend description]
Quadrant: [1-4 from clinical matrix]
Medical red flags: [list or "none identified"]
Missing values: [Free T3 / TPO / rT3, plan to request via PCP]
Clinical impression: [statement integrating thyroid panel with athletic
physiology and co-dependencies]
Action: [LEA intervention / iron repletion / endocrine referral / panel
re-draw with additions / no intervention indicated]
Follow-up: [date, plan, re-panel timing]
```
Assessment integrates the thyroid panel with the energy-availability and iron-status workup, the athletic-physiology context, and the symptomatic picture. Plan documents the intervention sequence, the medical-coordination communications, and the re-panel cadence. See [SOAP notes for sports dietitians](/blog/soap-notes-for-sports-dietitians) for the broader documentation framework.
The male-athlete thyroid question
Male athletes get less screening attention for thyroid presentations because the autoimmune-thyroid prevalence is lower and because the symptomatic picture overlaps with the [RED-S in male athletes](/blog/red-s-in-male-athletes-clinical-differential) differential. Male endurance athletes with chronic energy deficit, declining performance, persistent fatigue, and low-normal testosterone routinely show the low-T3 pattern as part of the broader RED-S picture. The thyroid panel that excludes Free T3 misses this signal; the workup that includes Free T3 catches the pattern that connects the energy deficit to the symptomatic decline. The intervention sequence is the energy-availability fix paired with the RED-S workup; the thyroid panel is informative but rarely the dominant driver in this presentation.
The masters-athlete thyroid trajectory
Masters athletes (typically 35+ for female athletes, 40+ for male athletes) have a rising baseline prevalence of subclinical hypothyroidism that overlaps with the athletic-physiology presentation and produces real interpretive complexity. The masters athlete with TSH 4.5 and declining splits may be in early Hashimoto, may be in energy-deficit-driven low-T3, may be in age-related subclinical hypothyroidism, or may be in some combination of all three. The workup discipline matters more in this population, not less, because the differential is wider. Run the full five-dimension workup, coordinate with the athlete's primary care for the panel additions, and resist the urge to either dismiss the case as "normal aging" or escalate it as a single-driver thyroid case.
Where platform tooling helps
The bottleneck in thyroid workup at scale is the data marshalling — the panel values translated into athletic-physiology interpretation, the missing values flagged for re-draw, the energy-availability and iron-status workups integrated into the four-quadrant matrix, the medical-coordination communications tracked across the care team, and the re-panel cadence held against the intervention timeline. The intake that has to manage all of this by hand drops the workup on busy weeks and the case surfaces months later with the athlete still under-performing on a levothyroxine prescription that was not the right intervention.
The leverage is a thyroid workup module that ingests the panel values, auto-flags TSH and Free T3 interpretation against the athletic-physiology frame, prompts for the missing values the four-quadrant matrix needs, integrates the LEA and iron workups, routes the case to the appropriate quadrant intervention, pre-populates the SOAP documentation, and tracks the medical-coordination communications and re-panel cadence. The RD's job becomes the clinical interpretation and the conversation, not the spreadsheet.
The chart trail is also defensible — every interpretation logged, every intervention tied to the workup-dimension that drove it, every medical referral documented with the workup data that justified it.
The bottom line
Thyroid panels in athletes carry a different interpretive load than in the sedentary population. The TSH reference range was calibrated on a non-athletic population. The standard PCP panel omits the values that drive the athletic differential. The dominant driver in most sports-RD thyroid cases is not the thyroid gland itself — it is chronic energy deficit producing low-T3 syndrome and a compensatory TSH rise, or iron deficiency producing a relative hypothyroid state through the thyroid-peroxidase co-factor pathway, or pre-clinical Hashimoto missed because TPO antibodies were not ordered. The workup that catches these drivers reads across the five dimensions, applies the four-quadrant matrix, coordinates with the medical team to fill in the missing values, and intervenes on the upstream physiology rather than reaching for levothyroxine adherence as the default.
The 42-year-old masters runner with declining splits and a TSH of 4.8 is rarely a simple hypothyroid case. She is, in the majority of presentations, an energy-deficit case with a compensatory TSH rise that will not resolve until the energy intervention is in place. The intake that runs the structured workup catches this. The intake that accepts the TSH at face value and counsels levothyroxine adherence does not.
[Calsanova's Dietitian plan](/signup?role=dietitian) ships a thyroid workup module with panel-value ingestion, athletic-physiology TSH and Free T3 interpretation, four-quadrant matrix routing, integrated LEA and iron-status workups, medical-coordination communications tracking, and re-panel cadence management with pre-populated SOAP documentation. Start your 30-day free trial and turn the thyroid panel from a single-number screen into a clinical instrument that catches the cases the standard PCP workup misses.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
Uric Acid Interpretation in Athletes: Why the High-Protein and High-Fructose Sports-Nutrition Diet Confounds the Standard Read, the Renal-vs-Metabolic Differential, and the Purine-Load Audit the Intake Must Run
A 34-year-old ultramarathon runner arrives at intake with a serum uric acid of 8.9 mg/dL flagged as 'hyperuricemia' on a routine metabolic panel, a primary-care referral to a rheumatologist for suspected gout despite no joint symptoms, and a nutrition history dominated by a self-directed high-protein endurance diet, a race-week carbohydrate load leaning on fructose-rich sports drinks, and a training-day sweat rate the workup did not capture. The standard uric acid interpretation was calibrated against a sedentary reference population and misses the athletic case where the elevation runs through a purine-load overlay, a sweat-driven concentration artifact, a fructose-driven hepatic de novo synthesis pathway, and (in a subset of cases) a genuine renal or metabolic disorder the panel is finally surfacing. Reading uric acid in isolation misses this case. Here is the structured uric acid workup for the sports-nutrition intake: the five-dimension interpretive frame, the purine-load audit against the protein and organ-meat pattern, the fructose-load overlay that separates the sports-drink and race-week driver, the sweat-concentration correction the endurance intake must run, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly against the rheumatology referral.
July 16, 2026
Liver Enzyme Interpretation in Athletes: Why AST and ALT Rise With Training, GGT as the Alcohol vs Training vs Supplement Disambiguator, and the Hepatotoxic-Supplement Differential in the Sports Nutrition Intake
A 27-year-old CrossFit competitor arrives at intake with an AST of 78 U/L and ALT of 62 U/L flagged as 'abnormal' on a routine hepatic panel, a primary-care recommendation to abstain from alcohol despite a self-reported intake of one to two drinks per week, and a supplement stack he has not disclosed to his primary care physician. The standard hepatic panel was calibrated against a general-population reference distribution and reads skeletal-muscle-derived AST and ALT elevations as hepatic dysfunction, and the alcohol-first differential misses the case where the actual driver runs through an undisclosed SARM cycle, a high-dose green tea extract, or a multi-ingredient formulation. Reading AST and ALT in isolation misses this case. Here is the structured liver enzyme workup for the sports-nutrition intake: the six-dimension interpretive frame, the GGT differential that separates alcohol-driven from training-driven from supplement-driven elevation, the CK and AST-to-ALT ratio overlay that surfaces the skeletal-muscle contribution, the hepatotoxic-supplement inventory the intake must directly capture, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly.
July 14, 2026
Male Athlete Testosterone Panel Interpretation: Total T, Free T, SHBG, and the RED-S vs Overtraining Syndrome vs Hypogonadism Differential in the Sports Nutrition Intake
A 34-year-old competitive road cyclist arrives at intake with a total testosterone of 312 ng/dL flagged 'low' by his primary care physician, a recommendation to consider testosterone replacement therapy, a training week averaging 18 hours at a self-reported energy intake of 2,900 kcal/day, and a body mass index of 21.1. He wants to know whether the low T is a diagnosis he should treat pharmacologically, a signal his fueling is under-supporting his training, or something else entirely. The standard testosterone assay was calibrated in a sedentary reference population and the 'low' flag under-differentiates the athletic case where a low-energy-availability driven suppression, a chronic overtraining-syndrome pattern, and a primary or secondary hypogonadism all present with overlapping numbers on a single draw. Reading total T in isolation misses the case. Here is the structured male-athlete testosterone workup for the sports nutrition intake: the six-dimension interpretive frame, the free T and SHBG follow-on, the LH and FSH differential that separates primary from secondary suppression, the energy-availability and training-load overlay that recalibrates the read, the four-quadrant clinical matrix, and the SOAP pattern that documents the case defensibly.
July 9, 2026